FORMYCON AG (FYB.DE) Stock Price & Overview
FRA:FYB • DE000A1EWVY8
Current stock price
The current stock price of FYB.DE is 18.88 EUR. Today FYB.DE is down by -2.07%. In the past month the price decreased by -20.67%. In the past year, price decreased by -31.59%.
FYB.DE Key Statistics
- Market Cap
- 333.61M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -9.60
- Dividend Yield
- N/A
FYB.DE Stock Performance
FYB.DE Stock Chart
FYB.DE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to FYB.DE. When comparing the yearly performance of all stocks, FYB.DE is a bad performer in the overall market: 92.69% of all stocks are doing better.
FYB.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to FYB.DE. FYB.DE may be in some trouble as it scores bad on both profitability and health.
FYB.DE Earnings
FYB.DE Forecast & Estimates
13 analysts have analysed FYB.DE and the average price target is 51.87 EUR. This implies a price increase of 174.76% is expected in the next year compared to the current price of 18.88.
For the next year, analysts expect an EPS growth of 12.95% and a revenue growth -9.62% for FYB.DE
FYB.DE Groups
Sector & Classification
FYB.DE Financial Highlights
Over the last trailing twelve months FYB.DE reported a non-GAAP Earnings per Share(EPS) of -9.6. The EPS decreased by -339.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -22.86% | ||
| ROE | -41.58% | ||
| Debt/Equity | 0.02 |
FYB.DE Ownership
FYB.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1AE | ARGENX SE | 25.34 | 38.133B | ||
| ARGX | ARGENX SE | 25.4 | 38.12B | ||
| 22UA | BIONTECH SE-ADR | N/A | 18.515B | ||
| ABVX | ABIVAX SA | N/A | 8.129B | ||
| 2X1 | ABIVAX SA | N/A | 8.097B | ||
| GXE | GALAPAGOS NV | N/A | 1.831B | ||
| GLPG | GALAPAGOS NV | N/A | 1.827B | ||
| NANO | NANOBIOTIX | N/A | 1.328B | ||
| IVA | INVENTIVA SA | N/A | 1.098B | ||
| 6IV | INVENTIVA SA | N/A | 1.098B | ||
| PHIL | PHILOGEN SPA | 18.09 | 663.748M | ||
| XUP | GENFIT | N/A | 468.027M | ||
| GNFT | GENFIT | 832.35 | 435.275M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About FYB.DE
Company Profile
Formycon AG engages in the manufacture of biosimilar drugs and formulations. The company is headquartered in Martinsried, Bayern and currently employs 245 full-time employees. The company went IPO on 2010-12-20. The firm is engaged in providing biosimilar drugs and formulations. The firm focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Company Info
IPO: 2010-12-20
FORMYCON AG
Fraunhoferstrasse 15, Planegg
Martinsried BAYERN DE
Employees: 250
Phone: 4989864667100
FORMYCON AG / FYB.DE FAQ
What does FORMYCON AG do?
Formycon AG engages in the manufacture of biosimilar drugs and formulations. The company is headquartered in Martinsried, Bayern and currently employs 245 full-time employees. The company went IPO on 2010-12-20. The firm is engaged in providing biosimilar drugs and formulations. The firm focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
What is the stock price of FORMYCON AG today?
The current stock price of FYB.DE is 18.88 EUR. The price decreased by -2.07% in the last trading session.
Does FYB stock pay dividends?
FYB.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of FYB stock?
FYB.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is FYB.DE stock listed?
FYB.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is the market capitalization of FYB stock?
FORMYCON AG (FYB.DE) has a market capitalization of 333.61M EUR. This makes FYB.DE a Small Cap stock.
Can you provide the ownership details for FYB stock?
You can find the ownership structure of FORMYCON AG (FYB.DE) on the Ownership tab.